Misplaced Pages

User:Elitre (WMF)/Sandbox: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
< User:Elitre (WMF) Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 11:49, 30 September 2013 editElitre (WMF) (talk | contribs)Extended confirmed users2,060 edits test← Previous edit Revision as of 11:52, 30 September 2013 edit undoElitre (WMF) (talk | contribs)Extended confirmed users2,060 editsm testTag: Visual editNext edit →
Line 34: Line 34:
| Fast response which occurs in minutes rather than multiple hours or days. Free antigens cross link the IgE on mast cells and basophils which causes a release of vasoactive biomolecules. | Fast response which occurs in minutes rather than multiple hours or days. Free antigens cross link the IgE on mast cells and basophils which causes a release of vasoactive biomolecules.


Testing can be done via skin test for specific IgE.<ref name=":1" /> Testing can be done via skin test for specific IgE.<ref name=":3" />
|- |-
! ] ! ]
Line 51: Line 51:
| Antibody (IgM or IgG) binds to antigen on foreign cell leading to cellular destruction via the ]. | Antibody (IgM or IgG) binds to antigen on foreign cell leading to cellular destruction via the ].


Testing includes both the direct and indirect Coombs test.<ref name=":2" /> Testing includes both the direct and indirect Coombs test.<ref name=":3" />
|- |-
! ] ! ]
Line 66: Line 66:
*(]) *(])
* Neutrophils * Neutrophils
| Antibody (IgG) binds to antigen on foreign cell leading to cellular destruction via neutrophils and the subsequent release of lysosomal enzymes.<ref>Le, Tau. First Aid for the USMLE Step 1 2013, p. 203-204</ref> | Antibody (IgG) binds to antigen on foreign cell leading to cellular destruction via neutrophils and the subsequent release of lysosomal enzymes.<ref name=":3">Le, Tau. First Aid for the USMLE Step 1 2013, p. 203-204</ref>
|- |-
! ] ! ]
Line 79: Line 79:
|| ||
*] *]
| T cells find antigen and activate macrophages.<ref>Le, Tau. First Aid for the USMLE Step 1 2013, p. 203-204</ref> | T cells find antigen and activate macrophages.<ref name=":3" />
|- |-
! V ! V

Revision as of 11:52, 30 September 2013

Not to be confused with Sensory processing disorder § Hyposensitivities and hypersensitivities. This page is about the medical condition. For the music album, see Hypersensitive. For the cause of dental pain, see Dentine hypersensitivity. Medical condition
Elitre (WMF)/Sandbox

Hypersensitivity (also called hypersensitivity reaction or intolerance) refers to undesirable reactions produced by the normal immune system, including allergies and autoimmunity. These reactions may be damaging, uncomfortable, or occasionally fatal. Hypersensitivity reactions require a pre-sensitized (immune) state of the host. The four-group classification was expounded by P. H. G. Gell and Robin Coombs in 1963.

Coombs and Gell classification

Comparison of hypersensitivity types
Type Alternative names Often mentioned disorders Mediators Description
I Allergy (immediate) Fast response which occurs in minutes rather than multiple hours or days. Free antigens cross link the IgE on mast cells and basophils which causes a release of vasoactive biomolecules.

Testing can be done via skin test for specific IgE.

II Cytotoxic, antibody-dependent Antibody (IgM or IgG) binds to antigen on foreign cell leading to cellular destruction via the MAC.

Testing includes both the direct and indirect Coombs test.

III Immune complex disease Antibody (IgG) binds to antigen on foreign cell leading to cellular destruction via neutrophils and the subsequent release of lysosomal enzymes.
IV Delayed-type hypersensitivity(DTH), cell-mediated immune memory response, antibody-independent T cells find antigen and activate macrophages.
V Autoimmune disease, receptor mediated (see below)

Type V

This is an additional type that is sometimes (often in the UK) used as a distinction from Type 2.

Instead of binding to cell surface components, the antibodies recognise and bind to the cell surface receptors, which either prevents the intended ligand binding with the receptor or mimics the effects of the ligand, thus impairing cell signaling.

Some clinical examples:

The use of Type 5 is rare. These conditions are more frequently classified as Type 2, though sometimes they are specifically segregated into their own subcategory of Type 2.

References

  1. Gell PGH, Coombs RRA, eds. Clinical Aspects of Immunology. 1st ed. Oxford, England: Blackwell; 1963.
  2. ^ Le, Tau. First Aid for the USMLE Step 1 2013, p. 203-204
  3. Black, CA. Delayed Type Hypersensitivity: Current Theories with an Historic Perspective Dermatol. Online J. (May 1999) 5(1):7 at http://dermatology.cdlib.org/DOJvol5num1/reviews/black.html
  4. http://emedicine.medscape.com/article/136118-overview
  5. Table 5-1 in:Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). Robbins Basic Pathology. Philadelphia: Saunders. ISBN 1-4160-2973-7.{{cite book}}: CS1 maint: multiple names: authors list (link) 8th edition.
  6. Rajan TV (2003). "The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation". Trends Immunol. 24 (7): 376–9. doi:10.1016/S1471-4906(03)00142-X. PMID 12860528. {{cite journal}}: Unknown parameter |month= ignored (help)

External links

Template:Medical conditions

Consequences of external causes
Temperature
Elevated
Reduced
Radiation
Oxygen
Pressure
Food
Maltreatment
Travel
Adverse effect
Other
Ungrouped
skin conditions
resulting from
physical factors
Lymphoid and complement disorders causing immunodeficiency
Primary
Antibody/humoral
(B)
Hypogammaglobulinemia
Dysgammaglobulinemia
Other
T cell deficiency
(T)

peripheral: Purine nucleoside phosphorylase deficiency

Severe combined
(B+T)
Acquired
Leukopenia:
Lymphocytopenia
Complement
deficiency
Hypersensitivity and autoimmune diseases
Type I/allergy/atopy
(IgE)
Foreign
Autoimmune
Type II/ADCC
Foreign
  • Hemolytic disease of the newborn
  • Autoimmune
    Cytotoxic
    "Type V"/receptor
    Type III
    (Immune complex)
    Foreign
    Autoimmune
    Type IV/cell-mediated
    (T cells)
    Foreign
    Autoimmune
    GVHD
    Unknown/
    multiple
    Foreign
    Autoimmune